Phase I and Pharmacokinetic Study of Gimatecan Given Orally Once a Week for 3 of 4 Weeks in Patients with Advanced Solid Tumors
Zhu, A. X., Ready, N., Clark, J. W., Safran, H., Amato, A., Salem, N., Pace, S., He, X., Zvereva, N., Lynch, T. J., Ryan, D. P., Supko, J. G.Volume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-08-1024
Date:
January, 2009
File:
PDF, 291 KB
english, 2009